Brief: Ultimovacs Announces Updated Positive Results From Phase I Trial

Zelluna ASA

19/10/2020 07:06

Oct 19 (Reuters) - Ultimovacs ASA  ULTIMO.OL :
    * ULTIMOVACS ANNOUNCES UPDATED POSITIVE RESULTS FROM PHASE I
TRIAL
    * RESULTS CONFIRM ACHIEVEMENT OF PRIMARY ENDPOINTS OF SAFETY
AND
TOLERABILITY AND INDICATE ENCOURAGING INITIAL SIGNALS OF
LONG-TERM SURVIVAL BENEFIT
    * OUTCOMES OF STUDY INCLUDED SAFETY AND TOLERABILITY OF UV1
AS
WELL AS INITIAL SIGNS OF CLINICAL RESPONSE
    * THROUGHOUT FOLLOW-UP PERIOD, NONE OF PATIENTS EXPERIENCED
UNEXPECTED SAFETY ISSUES RELATED TO UV1

Source text for Eikon:  ID:nObiKFj4Ka 
Further company coverage:  ULTIMO.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587785110;))